Novo Nordisk A/SNVONYSE
Loading
Price to Sales: Discounted ValuationCompressed
Percentile Rank0
3Y CAGR-27.0%
5Y CAGR-9.8%
Year-over-Year Change
Price-to-sales ratio
3Y CAGR
-27.0%/yr
vs +16.2%/yr prior
5Y CAGR
-9.8%/yr
Recent deceleration
Acceleration
-43.2pp
Decelerating
Percentile
P0
Near historical low
vs 5Y Ago
0.6x
Contraction
Streak
2 yr
Consecutive declineCompressed
| Period | Value | YoY Change |
|---|---|---|
| 2025 | 4.68 | -51.2% |
| 2024 | 9.57 | -28.9% |
| 2023 | 13.47 | +12.2% |
| 2022 | 12.01 | +0.1% |
| 2021 | 11.99 | +52.9% |
| 2020 | 7.84 | +4.3% |
| 2019 | 7.52 | +14.3% |
| 2018 | 6.58 | -11.0% |
| 2017 | 7.39 | +28.3% |
| 2016 | 5.76 | - |